Disease Risk Factor Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Disease Risk Factor Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arena Pharmaceuticals, Inc.
Pharmaceutical firm appoints new members to board of directors
October 17th, 2004
Arena Pharmaceuticals, Inc., (ARNA) announced the appointment of Harry F. Hixson, Jr., PhD, and Tina S. Nova, PhD, to the company's board of directors. Hixson and Nova add further depth to Arena's board by bringing knowledge and experience gained through executive management and director positions with several biotechnology companies. "We are delighted to welcome Hixson and Nova to our board of directors," said Jack Lief, Arena's president and CEO. "Both individuals possess impressive track records and extensive operating and scientific experience in our industry. Their insight will prove invaluable as we continue to develop our innovative...
Source: Disease Risk Factor Week (2004-10-17)
|
